2024-04-012025-03-312025-03-31false07208114BARNET ORTHODONTIC PRACTICE LIMITED2025-12-31falseiso4217:GBPxbrli:pure072081142024-03-31072081142025-03-31072081142024-04-012025-03-31072081142023-03-31072081142024-03-31072081142023-04-012024-03-3107208114bus:SmallEntities2024-04-012025-03-3107208114bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3107208114bus:FullAccounts2024-04-012025-03-3107208114bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107208114core:WithinOneYear2025-03-3107208114core:AfterOneYear2025-03-3107208114core:WithinOneYear2024-03-3107208114core:AfterOneYear2024-03-3107208114core:ShareCapital2025-03-3107208114core:SharePremium2025-03-3107208114core:RevaluationReserve2025-03-3107208114core:OtherReservesSubtotal2025-03-3107208114core:RetainedEarningsAccumulatedLosses2025-03-3107208114core:ShareCapital2024-03-3107208114core:SharePremium2024-03-3107208114core:RevaluationReserve2024-03-3107208114core:OtherReservesSubtotal2024-03-3107208114core:RetainedEarningsAccumulatedLosses2024-03-3107208114core:LandBuildings2025-03-3107208114core:PlantMachinery2025-03-3107208114core:Vehicles2025-03-3107208114core:FurnitureFittings2025-03-3107208114core:OfficeEquipment2025-03-3107208114core:NetGoodwill2025-03-3107208114core:IntangibleAssetsOtherThanGoodwill2025-03-3107208114core:ListedExchangeTraded2025-03-3107208114core:UnlistedNon-exchangeTraded2025-03-3107208114core:LandBuildings2024-03-3107208114core:PlantMachinery2024-03-3107208114core:Vehicles2024-03-3107208114core:FurnitureFittings2024-03-3107208114core:OfficeEquipment2024-03-3107208114core:NetGoodwill2024-03-3107208114core:IntangibleAssetsOtherThanGoodwill2024-03-3107208114core:ListedExchangeTraded2024-03-3107208114core:UnlistedNon-exchangeTraded2024-03-3107208114core:LandBuildings2024-04-012025-03-3107208114core:PlantMachinery2024-04-012025-03-3107208114core:Vehicles2024-04-012025-03-3107208114core:FurnitureFittings2024-04-012025-03-3107208114core:OfficeEquipment2024-04-012025-03-3107208114core:NetGoodwill2024-04-012025-03-3107208114core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107208114core:ListedExchangeTraded2024-04-012025-03-3107208114core:UnlistedNon-exchangeTraded2024-04-012025-03-3107208114core:MoreThanFiveYears2024-04-012025-03-3107208114core:Non-currentFinancialInstruments2025-03-3107208114core:Non-currentFinancialInstruments2024-03-3107208114dpl:CostSales2024-04-012025-03-3107208114dpl:DistributionCosts2024-04-012025-03-3107208114core:LandBuildings2024-04-012025-03-3107208114core:PlantMachinery2024-04-012025-03-3107208114core:Vehicles2024-04-012025-03-3107208114core:FurnitureFittings2024-04-012025-03-3107208114core:OfficeEquipment2024-04-012025-03-3107208114dpl:AdministrativeExpenses2024-04-012025-03-3107208114core:NetGoodwill2024-04-012025-03-3107208114core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107208114dpl:GroupUndertakings2024-04-012025-03-3107208114dpl:ParticipatingInterests2024-04-012025-03-3107208114dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3107208114core:ListedExchangeTraded2024-04-012025-03-3107208114dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3107208114core:UnlistedNon-exchangeTraded2024-04-012025-03-3107208114dpl:CostSales2023-04-012024-03-3107208114dpl:DistributionCosts2023-04-012024-03-3107208114core:LandBuildings2023-04-012024-03-3107208114core:PlantMachinery2023-04-012024-03-3107208114core:Vehicles2023-04-012024-03-3107208114core:FurnitureFittings2023-04-012024-03-3107208114core:OfficeEquipment2023-04-012024-03-3107208114dpl:AdministrativeExpenses2023-04-012024-03-3107208114core:NetGoodwill2023-04-012024-03-3107208114core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3107208114dpl:GroupUndertakings2023-04-012024-03-3107208114dpl:ParticipatingInterests2023-04-012024-03-3107208114dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3107208114core:ListedExchangeTraded2023-04-012024-03-3107208114dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3107208114core:UnlistedNon-exchangeTraded2023-04-012024-03-3107208114core:NetGoodwill2025-03-3107208114core:IntangibleAssetsOtherThanGoodwill2025-03-3107208114core:LandBuildings2025-03-3107208114core:PlantMachinery2025-03-3107208114core:Vehicles2025-03-3107208114core:FurnitureFittings2025-03-3107208114core:OfficeEquipment2025-03-3107208114core:AfterOneYear2025-03-3107208114core:WithinOneYear2025-03-3107208114core:ListedExchangeTraded2025-03-3107208114core:UnlistedNon-exchangeTraded2025-03-3107208114core:ShareCapital2025-03-3107208114core:SharePremium2025-03-3107208114core:RevaluationReserve2025-03-3107208114core:OtherReservesSubtotal2025-03-3107208114core:RetainedEarningsAccumulatedLosses2025-03-3107208114core:NetGoodwill2024-03-3107208114core:IntangibleAssetsOtherThanGoodwill2024-03-3107208114core:LandBuildings2024-03-3107208114core:PlantMachinery2024-03-3107208114core:Vehicles2024-03-3107208114core:FurnitureFittings2024-03-3107208114core:OfficeEquipment2024-03-3107208114core:AfterOneYear2024-03-3107208114core:WithinOneYear2024-03-3107208114core:ListedExchangeTraded2024-03-3107208114core:UnlistedNon-exchangeTraded2024-03-3107208114core:ShareCapital2024-03-3107208114core:SharePremium2024-03-3107208114core:RevaluationReserve2024-03-3107208114core:OtherReservesSubtotal2024-03-3107208114core:RetainedEarningsAccumulatedLosses2024-03-3107208114core:NetGoodwill2023-03-3107208114core:IntangibleAssetsOtherThanGoodwill2023-03-3107208114core:LandBuildings2023-03-3107208114core:PlantMachinery2023-03-3107208114core:Vehicles2023-03-3107208114core:FurnitureFittings2023-03-3107208114core:OfficeEquipment2023-03-3107208114core:AfterOneYear2023-03-3107208114core:WithinOneYear2023-03-3107208114core:ListedExchangeTraded2023-03-3107208114core:UnlistedNon-exchangeTraded2023-03-3107208114core:ShareCapital2023-03-3107208114core:SharePremium2023-03-3107208114core:RevaluationReserve2023-03-3107208114core:OtherReservesSubtotal2023-03-3107208114core:RetainedEarningsAccumulatedLosses2023-03-3107208114core:AfterOneYear2024-04-012025-03-3107208114core:WithinOneYear2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3107208114core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3107208114core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3107208114core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3107208114core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3107208114core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3107208114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3107208114core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3107208114core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3107208114core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3107208114core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3107208114core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3107208114bus:Director12024-04-012025-03-3107208114core:FurnitureFittingsToolsEquipment2024-03-3107208114core:FurnitureFittingsToolsEquipment2024-04-012025-03-3107208114core:FurnitureFittingsToolsEquipment2025-03-31

BARNET ORTHODONTIC PRACTICE LIMITED

Registered Number
07208114
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

BARNET ORTHODONTIC PRACTICE LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

Coonar Amit Kaur Dr.

Registered Address

118 Mercers Road
Tufnell Park
N19 4PU

Registered Number

07208114 (England and Wales)
BARNET ORTHODONTIC PRACTICE LIMITED
Statement of Financial Position
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets367,958112,381
Tangible assets61,121-
69,079112,381
Current assets
Debtors746,0155,691
Cash at bank and on hand222,318258,526
268,333264,217
Creditors amounts falling due within one year8(6,934)(21,361)
Net current assets (liabilities)261,399242,856
Total assets less current liabilities330,478355,237
Net assets330,478355,237
Capital and reserves
Called up share capital103103
Profit and loss account330,375355,134
Shareholders' funds330,478355,237
The financial statements were approved and authorised for issue by the Director on 31 December 2025, and are signed on its behalf by:
Coonar Amit Kaur Dr.
Director
Registered Company No. 07208114
BARNET ORTHODONTIC PRACTICE LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number is 07208114 and registered office address is 118 Mercers Road, Tufnell Park, London, England, N19 4PU.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable and represents revenue earned from the provision of dental services during the period. As the company is not registered for VAT, turnover is stated inclusive of any irrecoverable VAT.
Revenue from rendering of services
Revenue from the rendering of dental services is recognised by reference to the stage of completion at the reporting date. This is typically determined based on the date the service is performed. For longer-term treatment plans, revenue is recognised based on the proportion of services delivered up to the reporting date, where the outcome can be reliably estimated. Where the outcome of a course of treatment cannot be estimated reliably, revenue is recognised only to the extent that the expenses incurred are recoverable. As the company is not registered for VAT, revenue is stated inclusive of any VAT charged to patients
Interest income
Interest income is recognised using the effective interest rate method.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Intangible assets
Intangible assets are stated at cost less accumulated amortization and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortization is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill & other Intangible assets are amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognized.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows: All tangible fixed assets have been fully depreciated as at the balance sheet date. Accordingly, no depreciation charge has been recorded in the current year.

Straight line (years)
Plant and machinery4
Fixtures and fittings4
Office Equipment4
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
2.Average number of employees

20252024
Average number of employees during the year11
3.Intangible assets

Goodwill

Other

Total

£££
Cost or valuation
At 01 April 24441,8262,404444,230
At 31 March 25441,8262,404444,230
Amortisation and impairment
At 01 April 24331,369480331,849
Charge for year44,18324044,423
At 31 March 25375,552720376,272
Net book value
At 31 March 2566,2741,68467,958
At 31 March 24110,4571,924112,381
4.Useful life of intangible assets
The company previously amortised goodwill over a 20-year useful life. Following a review to align with industry practice and HMRC guidelines, the estimated useful life has been revised to 10 years, effective 31 March 2025. This change is treated prospectively. The carrying amount of goodwill at 31 March 2025 will be amortised over the remaining period of the revised 10-year life, resulting in the asset being fully amortised within the next two financial years. The current year’s amortisation charge reflects this revision, and no adjustments have been made to prior periods.
5.Impairment of intangible assets
At each reporting date, the company assesses whether there is any indication that its intangible assets may be impaired. Where such indicators exist, the recoverable amount of the asset is estimated. Based on management’s review at 31 March 2025, no impairment charge was deemed necessary. The carrying value of goodwill and other intangibles continues to reflect expected future economic benefits.
6.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 April 2487,41827,13838,046152,602
Additions--1,2981,298
At 31 March 2587,41827,13839,344153,900
Depreciation and impairment
At 01 April 2487,41827,13838,046152,602
Charge for year--177177
At 31 March 2587,41827,13838,223152,779
Net book value
At 31 March 25--1,1211,121
At 31 March 24----
7.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables5,0285,220
Other debtors40,987-
Prepayments and accrued income-471
Total46,0155,691
As at balance sheet date on 31st March 2025 , other debtors comprises the below: Directors loan account : £40,986.17
8.Creditors: amounts due within one year

2025

2024

££
Taxation and social security4,0824,183
Other creditors2,85217,178
Total6,93421,361
As at the balance sheet date of 31 March 2025, other creditors comprise the following: Wages payable :£873.33 Accruals : £1,980
9.Share capital
Authorised Share Capital: The company has authorised ordinary shares as follows: Ordinary Shares: £100 (No changes from 1 April 2024 to 31 March 2025). Ordinary Share Capital B: £1 Ordinary Share Capital C: £1 Ordinary Share Capital D: £1 Total Ordinary Share Capital: As of 31 March 2025, the total ordinary share capital remains at £103, consistent with the previous year.